Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001209191-22-012399

Director bought 151,472 shares at an average $1.45 ($219,667)

From the SEC's structured data for this filing

Trades in this filing

MOTT DAVID M · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-18 Purchase : show line 1 in the form +50,398 $1.30 $65,517 128,150 D
2022-02-22 Purchase : show line 2 in the form +65,817 $1.56 $102,675 193,967 D
2022-02-23 Purchase : show line 3 in the form +35,257 $1.46 $51,475 229,224 D
Open-market purchases · 151,472 sh · avg $1.45 · $219,667
Loading xslF345X03/doc4.xml…